Rationale for Combining PARP Inhibitors With Other Therapies in Prostate Cancer
Episode Ep 53 13 min 42s

Rationale for Combining PARP Inhibitors With Other Therapies in Prostate Cancer

In this podcast episode, listen to medical oncologists Karim Fizazi, MD, PhD, and Joaquin Mateo, MD, PhD, discuss the rationale for using PARP inhibitors in combination with other therapies for prostate cancer.

Community discussion